News Updates (12)

Immunovia Appoints Jeff Borcherding as Global CEO to Accelerate Pancreatic Cancer Detection in the US Market

Immunovia AB, a biotechnology company specializing in the development of blood-based tests for early detection of cancer, has announced the appointment of Jeff Borcherding as its new global CEO. Borcherding, who has been President of Immunovia’s US operation since April 2022, will replace Philipp Matthieu as the Company shifts its focus to the United States…

Read More
News Updates (13)

Eiger BioPharmaceuticals Announces Key Executive Appointments

Eiger BioPharmaceuticals, a commercial-stage biopharmaceutical company, announced on Wednesday the appointment of William G. Kachioff as Chief Financial Officer and James A. Vollins as General Counsel, Chief Compliance Officer, and Corporate Secretary. The company, which is focused on developing innovative therapies for hepatitis delta virus (HDV) and other serious diseases, said the appointments come at…

Read More
News Updates (18)

CapMan Buyout Appoints Maija Joutsenkoski as Partner: A Key Leader with Decade-Long Industry and Private Equity Experience

Helsinki-based private equity firm CapMan Buyout has announced the appointment of Maija Joutsenkoski as Partner, effective April 1st. Ms. Joutsenkoski, who joined the company in 2022, has demonstrated her leadership skills and strong drive during her short tenure, making her a valuable addition to the team.   A Decade-Long Experience in Private Equity and Industry…

Read More
News Updates (14)

Karolinska Institutet to confer Honorary Doctorates to Two Distinguished Individuals

Karolinska Institutet, a world-renowned medical university in Stockholm, Sweden, has announced that it will confer honorary doctorates to two individuals for their outstanding contributions to the field of medicine. The formal ceremony will take place at Stockholm City Hall on 12 May, as part of the doctoral conferment ceremony.   Pioneering Geriatric Medicine Specialist to…

Read More
News Updates (18)

Aqilion and Merck Partner to Develop Groundbreaking Treatments for Chronic Inflammation

Swedish biotech firm Aqilion has partnered with global pharmaceutical company Merck to develop new treatments for chronic inflammation and immune dysfunction. The strategic collaboration will focus on discovering and commercializing inhibitors of the TAK1 protein, which is a crucial mediator in the inflammatory process. Merck’s upfront cash payment of EUR 10 million to Aqilion is…

Read More
Novolex Names Daniel L. Rikard as New General Counsel to Strengthen Legal Strategy

Novolex Names Daniel L. Rikard as New General Counsel to Strengthen Legal Strategy

In a move to strengthen its legal strategy and manage risks, Novolex, a leading manufacturer of diverse packaging products, has appointed Daniel L. Rikard as their new General Counsel. With this appointment, Rikard will oversee the company’s legal matters and lead the legal organization. Experience and Expertise: Rikard brings over 30 years of experience in…

Read More